MEI Pharma, Inc. (MEIP)

[EM]

Thanks.

I took a look into CPXX and his VYXEOS (competitor of MEIP that did +1000% in a year after showing great data results) bought out by Jazz Pharmaceuticals last year.

MEIP
Drug Candidate: Pracinostat
Phase III Study: Q1 2017
Combo: Aza
(Last Reported Clinical Data)
CR Rate: 42% (21/50)
Median OS: 19.1 months (95%CI: 10.7-26.5)

CPXX
Drug Candidate: VYXEOS
Sponsor: Celator (now Jazz Pharmaceuticals)
Phase III Study: Completed
(Last Reported Clinical Data)
CR Rate: 37%
Median OS: 9.6 months

Pracinostat looks really better.

Here an article with the comparison.

http://seekingalpha.com/article/3966193-mei-pharma-poised-move-higher